Clinical Trial Update: Nelmastobart in Combination With Docetaxel in Non Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

This clinical trial update notes a Phase 2 study of Nelmastobart in combination with docetaxel for non-small cell lung cancer, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• Nelmastobart (nelmastobart)

Snippet

Sponsor: STCube, Inc. | Conditions: Non Small Cell Lung Cancer | Phase 2 | Status: RECRUITING